or Try an Advanced Search...

    Treatment Of Lupus Stocks List

    Symbol Grade Name % Change
    AUPH F Aurinia Pharmaceuticals Inc -1.35
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Autoimmune Disease Biopharmaceutical Clinical Development Drugs Immunosuppressants Life Sciences Lupus Lupus Nephritis Medicine Nephritis Nephrology Peptides

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Lupus stocks.

    Symbol Grade Name Weight
    BBP D BioShares Biotechnology Products Fund 1.13
    SBIO D ALPS Medical Breakthroughs ETF 0.48
    BTEC C Principal Healthcare Innovators Index ETF 0.19
    VFMO C Vanguard U.S. Momentum Factor ETF 0.1
    IBBQ C Invesco Nasdaq Biotechnology ETF 0.08
    View all Treatment Of Lupus ETFs...
    Compare ETFs
    Compare BTEC to VFMO Compare SBIO to BTEC Compare SBIO to IBBQ

        Treatment Of Lupus Stocks Recent News

        Date Stock Title
        May 3 AUPH Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
        May 2 AUPH Aurinia Pharma: A Welcome Change To The Thesis (Rating Upgrade)
        May 2 AUPH Aurinia Pharmaceuticals Inc. (AUPH) Q1 2024 Earnings Call Transcript
        May 2 AUPH Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
        May 2 AUPH Aurinia Pharma GAAP EPS of -$0.07 beats by $0.07, revenue of $50.3M beats by $3.23M
        May 2 AUPH Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
        May 1 AUPH Aurinia Pharma Q1 2024 Earnings Preview
        May 1 AUPH Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
        Apr 30 AUPH Aurinia: Updated Lupkynis Label Should Keep Sales Growth Momentum Going
        Apr 30 AUPH Aurinia gains on Lupkynis label update
        Apr 30 AUPH The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
        Related Industries: Biotechnology
        Related Stock Lists: Autoimmune Disease Biopharmaceutical Clinical Development Drugs Immunosuppressants Life Sciences Lupus Lupus Nephritis Medicine Nephritis Nephrology Peptides
        Treatment Of Lupus

        Browse All Tags